Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
This is a single arm open label pilot phase II trial of Regorafenib PO plus 5-FU/LV infusion in 15 mCRC patients who progressed on prior Regorafenib monotherapy as well as 5-FU containing chemotherapy combinations.The study will enroll mCRC patients with prior progression on standard multi-agent combination chemotherapy and progression on regorafenib monotherapy.
创建时间：
2017-10-15
